Expression of Cell Cycle Biomarkers and Telomere Length in Papillary Thyroid Carcinoma: A Comparative Study Between Radiation-Associated and Spontaneous Cancers

被引:6
作者
Achille, Mihaela [1 ,4 ]
Boukheris, Houda [5 ]
Caillou, Bernard [2 ]
Talbot, Monique [2 ]
de Vathaire, Florent [5 ]
Sabatier, Laure [4 ]
Desmaze, Chantal [4 ]
Schlumberger, Martin [3 ]
Soria, Jean-Charles [1 ,4 ]
机构
[1] Inst Gustave Roussy, Dept Med, F-94805 Villejuif, France
[2] Inst Gustave Roussy, Dept Biopathol, F-94805 Villejuif, France
[3] Inst Gustave Roussy, Dept Nucl Med, F-94805 Villejuif, France
[4] CEA, DRR, DSV, Lab Radiobiol & Oncol, Villejuif, France
[5] Univ Paris 11, Inst Gustave Roussy, INSERM, Natl Inst Hlth & Med Res,U605, Villejuif, France
来源
AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS | 2009年 / 32卷 / 01期
关键词
papillary thyroid carcinoma; radiation-associated; cyclins; telomere length; ATOMIC-BOMB SURVIVORS; D1; OVEREXPRESSION; BREAST-CANCER; PROTEINS; TUMORS; B1; CDC2; P27;
D O I
10.1097/COC.0b013e3181783336
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Objective: Radiation exposure during childhood is the only well-established risk factor for papillary thyroid carcinoma (PTC). To better define the biologic profile of radiation-induced and sporadic PTC, we compared in these two groups of PTC the expression of cell cycle regulatory proteins and telomere length. Methods: Cell cycle markers (cyclin A, B1, D1, E, and Ki67) were evaluated on 100 PTC specimens (26 radiation-induced and 74 sporadic PTCs). The expression of cell cycle regulators was studied using immunohistochemistry; telomere length heterogeneity was studied using in situ hybridization in a subset of 16 formalin-fixed samples (8 radiation-induced and 8 sporadic PTCs). Results: At multivariate analysis, only cytoplasmic cyclin E staining was overexpressed in sporadic cases (P = 0.006). The other cell cycle markers and telomere length did not differ significantly between sporadic PTC and radiation-induced PTC. Conclusions: These markers cannot be used to differentiate radiation-induced from sporadic PTCs.
引用
收藏
页码:1 / 8
页数:8
相关论文
共 39 条
[1]   Cyclin D1 overexpression in thyroid carcinomas: Relation with clinico-pathological parameters, retinoblastoma gene product, and Ki67 labeling index [J].
Basolo, F ;
Caligo, MA ;
Pinchera, A ;
Fedeli, F ;
Baldanzi, A ;
Miccoli, P ;
Iacconi, P ;
Fontanini, G ;
Pacini, F .
THYROID, 2000, 10 (09) :741-746
[2]   Abnormal expression of CCND1 and RB1 in resection margin epithelia of lung cancer patients [J].
Betticher, DC ;
Heighway, J ;
Thatcher, N ;
Hasleton, PS .
BRITISH JOURNAL OF CANCER, 1997, 75 (12) :1761-1768
[3]   High prevalence of activating ret proto-oncogene rearrangements, in thyroid tumors from patients who had received external radiation [J].
Bounacer, A ;
Wicker, R ;
Caillou, B ;
Cailleux, AF ;
Sarasin, A ;
Schlumberger, M ;
Suarez, HG .
ONCOGENE, 1997, 15 (11) :1263-1273
[4]  
Brzezinski J, 2005, CLIN CANCER RES, V11, P1037
[5]   Cyclin E expression in papillary thyroid carcinoma: Relation to staging [J].
Brzezinski, J ;
Migodzinski, A ;
Gosek, A ;
Tazbir, J ;
Dedecjus, M .
INTERNATIONAL JOURNAL OF CANCER, 2004, 109 (01) :102-105
[6]   Oncogenic AKAP9-BRAF fusion is a novel mechanism of MAPK pathway activation in thyroid cancer [J].
Ciampi, R ;
Knauf, JA ;
Kerler, R ;
Gandhi, M ;
Zhu, ZW ;
Nikiforova, MN ;
Rabes, HM ;
Fagin, JA ;
Nikiforov, YE .
JOURNAL OF CLINICAL INVESTIGATION, 2005, 115 (01) :94-101
[7]   Absence of a specific radiation signature in post-Chernobyl thyroid cancers [J].
Detours, V ;
Wattel, S ;
Venet, D ;
Hutsebaut, N ;
Bogdanova, T ;
Tronko, MD ;
Dumont, JE ;
Franc, B ;
Thomas, G ;
Maenhaut, C .
BRITISH JOURNAL OF CANCER, 2005, 92 (08) :1545-1552
[8]   How thyroid tumors start and why it matters: kinase mutants as targets for solid cancer pharmacotherapy [J].
Fagin, JA .
JOURNAL OF ENDOCRINOLOGY, 2004, 183 (02) :249-256
[9]  
Hassan KA, 2001, CLIN CANCER RES, V7, P2458
[10]   Telomerase activity in benign and malignant thyroid tumors [J].
Haugen, BR ;
Nawaz, S ;
Markham, N ;
Hashizumi, T ;
Shroyer, AL ;
Werness, B ;
Shroyer, KR .
THYROID, 1997, 7 (03) :337-342